title: Aspirin bleeding in perspective.
abstract: Aspirin therapy should be an adjunct to the medical management of patients who have had a vascular event but the role of aspirin prophylaxis in the primary prevention of vascular events is less clear. This benefit-versus-risk balance may, however, be influenced by evidence that aspirin reduces bowel cancer risk. Wider aspirin use could lead to more advice being sought on its use from community pharmacists and general practitioners. Yet 10% of those taking aspirin experience symptoms that negatively affect their daily quality of life. These symptoms, such as heartburn, may discourage more individuals from taking aspirin than would the risk of bleeding.
authors: Department of Primary Care and Public Health, Cardiff University, University Hospital of Wales, Wales, UK. morgan@fforrdbeck.fsnet.co.uk
authors: Gareth
authors: G
authors: Morgan
authors: Peter
authors: P
authors: Elwood
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D018570:Risk Assessment
chemical_list: D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D001241:Aspirin